Abstract

We appreciate the insightful comments and agree that understanding the impact of PE acquisitions on cost, utilization, and quality in urology is critical. It may take years for these assessments to fully mature. In the interim, analyses in other similar healthcare industries have found reasons for both caution and optimism and suggest that there is no uniform strategy employed by investors. In some instances, strategies to maximize profit can be at odds with priorities for cost-effectiveness and safety.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.